C6ORF115 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.170100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.079800E-02
Normal-vs-Stage2
4.438000E-02
Normal-vs-Stage3
3.279200E-01
Normal-vs-Stage4
1.819960E-02
Stage1-vs-Stage2
1.806380E-01
Stage1-vs-Stage3
3.506200E-01
Stage1-vs-Stage4
7.044400E-01
Stage2-vs-Stage3
7.389200E-01
Stage2-vs-Stage4
4.736400E-01
Stage3-vs-Stage4
5.500600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.838300E-02
Normal-vs-AfricanAmerican
4.710200E-02
Normal-vs-Asian
2.599000E-01
Caucasian-vs-AfricanAmerican
5.947200E-01
Caucasian-vs-Asian
3.097800E-01
AfricanAmerican-vs-Asian
8.540600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.980300E-02
Normal-vs-Female
8.954300E-02
Male-vs-Female
3.159400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.521230E-01
Normal-vs-Age(41-60Yrs)
3.155800E-02
Normal-vs-Age(61-80Yrs)
5.014200E-02
Normal-vs-Age(81-100Yrs)
8.724200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.186200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.100800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.525600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.058600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.339600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.782000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.237960E-01
Normal-vs-Daily Drinker
3.062600E-03
Normal-vs-Weekly Drinker
2.594200E-01
Normal-vs-Occasional Drinker
2.697400E-01
Normal-vs-Social Drinker
5.185800E-04
Non Drinker-vs-Daily Drinker
8.680000E-02
Non Drinker-vs-Weekly Drinker
7.902400E-01
Non Drinker-vs-Occasional Drinker
9.863800E-01
Non Drinker-vs-Social Drinker
8.316200E-02
Daily Drinker-vs-Weekly Drinker
1.518370E-01
Daily Drinker-vs-Occasional Drinker
2.270000E-01
Daily Drinker-vs-Social Drinker
8.776000E-01
Weekly Drinker-vs-Occasional Drinker
8.524400E-01
Weekly Drinker-vs-Social Drinker
1.701030E-01
Occasional Drinker-vs-Social Drinker
2.540600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.764200E-01
Normal-vs-Grade 2
8.765000E-01
Normal-vs-Grade 3
9.071600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.874400E-01
Grade 1-vs-Grade 3
8.871200E-01
Grade 1-vs-Grade 4
8.764200E-01
Grade 2-vs-Grade 3
6.232800E-01
Grade 2-vs-Grade 4
8.765000E-01
Grade 3-vs-Grade 4
9.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.790300E-02
Normal-vs-NonDiabetic
5.250400E-02
Diabetic-vs-NonDiabetic
7.904400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.163690E-02
Normal-vs-NoPancreatitis
6.654000E-02
Pancreatitis-vs-NoPancreatitis
9.409000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.590200E-02
Normal-vs-N1
3.174100E-02
N0-vs-N1
8.350600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.289800E-02
Normal-vs-TP53-NonMutant
8.176400E-02
TP53-Mutant-vs-TP53-NonMutant
4.456800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
